Design and synthesis of 4,5-diphenyl-imidazol-1,2,3-triazole hybrids as new anti-diabetic agents: in vitro α-glucosidase inhibition, kinetic and docking studies

被引：0
|
作者：
Mohammad Sadegh Asgari
Maryam Mohammadi-Khanaposhtani
Zeinab Sharafi
Mohammad Ali Faramarzi
Hossein Rastegar
Ensieh Nasli Esfahani
Fatemeh Bandarian
Parviz Ranjbar Rashidi
Rahmatollah Rahimi
Mahmood Biglar
Mohammad Mahdavi
Bagher Larijani
机构：
[1] University of Tehran,School of Chemistry, College of Science
[2] Babol University of Medical Sciences,Cellular and Molecular Biology Research Center, Health Research Institute
[3] Lorestan University of Medical Sciences,Razi Herbal Medicines Research Center
[4] Tehran University of Medical Sciences,Department of Pharmaceutical Biotechnology, Faculty of Pharmacy and Biotechnology Research Center
[5] MOHE,Food and Drug Research Institute, Food and Drug Administration
[6] University of Medical Sciences,Diabetes Research Center, Endocrinology and Metabolism Clinical Sciences Institute
[7] Iran University of Science and Technology,Department of Chemistry
[8] Tehran University of Medical Sciences,Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute
来源：
Molecular Diversity | 2021年 / 25卷
关键词：
Anti-diabetic agents; Kinetic study; α-Glucosidase; Molecular docking; 4,5-Diphenyl-imidazol,1,2,3-triazole;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：877 / 888
页数：11
相关论文
共 50 条
  • [1] Design and synthesis of 4,5-diphenyl-imidazol-1,2,3-triazole hybrids as new anti-diabetic agents: in vitro α-glucosidase inhibition, kinetic and docking studies
    Asgari, Mohammad Sadegh
    Mohammadi-Khanaposhtani, Maryam
    Sharafi, Zeinab
    Faramarzi, Mohammad Ali
    Rastegar, Hossein
    Esfahani, Ensieh Nasli
    Bandarian, Fatemeh
    Rashidi, Parviz Ranjbar
    Rahimi, Rahmatollah
    Biglar, Mahmood
    Mandavi, Mohammad
    Larijani, Bagher
    MOLECULAR DIVERSITY, 2021, 25 (02) : 877 - 888
  • [2] Biscoumarin-1,2,3-triazole hybrids as novel anti-diabetic agents: Design, synthesis, in vitro α-glucosidase inhibition, kinetic, and docking studies
    Asgari, Mohammad Sadegh
    Mohammadi-Khanaposhtani, Maryam
    Kiani, Mitra
    Ranjbar, Parviz Rashidi
    Zabihi, Ebrahim
    Pourbagher, Roghayeh
    Rahimi, Rahmatollah
    Faramarzi, Mohammad Ali
    Biglar, Mahmood
    Larijani, Bagher
    Mahdavi, Mohammad
    Hamedifar, Haleh
    Hajimiri, Mir Hamed
    BIOORGANIC CHEMISTRY, 2019, 92
  • [3] Design and synthesis of novel quinazolinone-1,2,3-triazole hybrids as new anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and docking study
    Saeedi, Mina
    Mohammadi-Khanaposhtani, Maryam
    Pourrabia, Parvaneh
    Razzaghi, Nima
    Ghadimi, Reza
    Imanparast, Somaye
    Faramarzi, Mohammad Ali
    Bandarian, Fatemeh
    Esfahani, Ensieh Nasli
    Safavi, Maliheh
    Rastegar, Hossein
    Larijani, Bagher
    Mandavi, Mohammad
    Akbarzadeh, Tahmineh
    BIOORGANIC CHEMISTRY, 2019, 83 : 161 - 169
  • [4] Design and synthesis of new benzylidene-quinazolinone hybrids as potential anti-diabetic agents: In vitro α-glucosidase inhibition, and docking studies
    Khalifa, Mohamed M.
    Sakr, Helmy M.
    Ibrahim, Albaraa
    Mansour, Ahmed M.
    Ayyad, Rezk R.
    JOURNAL OF MOLECULAR STRUCTURE, 2022, 1250
  • [5] Discovery of novel 4,5-diphenyl-imidazol-α-aminophosphonate hybrids as promising anti-diabetic agents: Design, synthesis, in vitro, and in silico enzymatic studies
    Zareei, Samira
    Ranjbar, Sara
    Mohammadi, Mohammad
    Ghasemi, Younes
    Golestanian, Sahand
    Avizheh, Laya
    Moazzam, Ali
    Larijani, Bagher
    Mohammadi-Khanaposhtani, Maryam
    Tarahomi, Mohammad Majid
    Mahdavi, Mohammad
    Sadeghian, Nastaran
    Taslimi, Parham
    BIOORGANIC CHEMISTRY, 2023, 141
  • [6] New phthalimide-benzamide-1,2,3-triazole hybrids; design, synthesis, α-glucosidase inhibition assay, and docking study
    Seyed Esmaeil Sadat-Ebrahimi
    Abbas Rahmani
    Maryam Mohammadi-Khanaposhtani
    Negar jafari
    Somayeh Mojtabavi
    Mohammad Ali Faramarzi
    Mehdi Emadi
    Azadeh Yahya-Meymandi
    Bagher Larijani
    Mahmoud Biglar
    Mohammad Mahdavi
    Medicinal Chemistry Research, 2020, 29 : 868 - 876
  • [7] New phthalimide-benzamide-1,2,3-triazole hybrids; design, synthesis, α-glucosidase inhibition assay, and docking study
    Sadat-Ebrahimi, Seyed Esmaeil
    Rahmani, Abbas
    Mohammadi-Khanaposhtani, Maryam
    Jafari, Negar
    Mojtabavi, Somayeh
    Faramarzi, Mohammad Ali
    Emadi, Mehdi
    Yahya-Meymandi, Azadeh
    Larijani, Bagher
    Biglar, Mahmoud
    Mahdavi, Mohammad
    MEDICINAL CHEMISTRY RESEARCH, 2020, 29 (05) : 868 - 876
  • [8] Novel Pyrano[3,2-c]quinoline-1,2,3-triazole Hybrids as Potential Anti-Diabetic Agents: In Vitro α-Glucosidase Inhibition, Kinetic, and Molecular Dynamics Simulation
    Esmaili, Soheila
    Ebadi, Ahmad
    Khazaei, Ardeshir
    Ghorbani, Hamideh
    Faramarzi, Mohammad Ali
    Mojtabavi, Somayeh
    Mahdavi, Mohammad
    Najafi, Zahra
    ACS OMEGA, 2023, 8 (26): : 23412 - 23424
  • [9] Design and synthesis of new fused carbazole-imidazole derivatives as anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and in silico studies
    Adib, Mehdi
    Peytam, Fariba
    Shourgeshty, Reihaneh
    Mohammadi-Khanaposhtani, Maryam
    Jahani, Mehdi
    Imanparast, Somaye
    Faramarzi, Mohammad Ali
    Larijani, Bagher
    Moghadamnia, Ali Akbar
    Esfahani, Ensieh Nasli
    Bandarian, Fatemeh
    Mahdavi, Mohammad
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (05) : 713 - 718
  • [10] Synthesis, in vitro antimicrobial evaluation, and molecular docking studies of new isatin-1,2,3-triazole hybrids
    El Malah, Tamer
    Farag, Hanaa
    Hemdan, Bahaa A.
    Mageid, Randa E. Abdel
    Abdelrahman, Mohamad T.
    El-Manawaty, May A.
    Nour, Hany F.
    JOURNAL OF MOLECULAR STRUCTURE, 2022, 1250
12345